Inflammatory bowel diseases (IBDs) are chronic intestinal diseases, frequently associated with comorbid psychological and cognitive deficits. These neuropsychiatric effects include anxiety, depression, and memory impairments that can be seen both during active disease and following remission and are more frequently seen in pediatric patients. The mechanism(s) through which these extra-intestinal deficits develop remain unknown and the study of these phenomenon are hampered by a lack of murine pediatric IBD models. Herein we describe microbiota-gut-brain (MGB) axis deficits following induction of colitis in a pediatric setting. Acute colitis was induced by administration of 2% dextran sodium sulfate (DSS) for 5 days starting at weaning (post-natal day [P]21) causing reduced weight gain, colonic shortening, and colonic inflammation by 8 days post-DSS (P29), which were mostly resolved in adult (P56) mice. Despite resolution of acute disease, cognitive deficits (novel object recognition task) and anxiety-like behavior (light/dark box) were identified, in the absence of changes in exploratory behavior (open field test) in P56 mice previously treated with DSS at weaning. Behavioral deficits were found in conjunction with neuroinflammation, decreased neurogenesis, and altered expression of pattern recognition receptor genes in the hippocampus. In addition, persistent alterations in the gut microbiota composition were observed at P56, including reduced butyrate-producing species. Taken together, these results describe for the first time the presence of MGB axis deficits following induction of colitis at weaning, which persist in adulthood.
Background Inflammatory bowel diseases (IBD) are chronic intestinal diseases affecting over 1.4 million Americans. Pediatric patients are especially vulnerable to the psychiatric effects seen in IBD as they are still undergoing brain maturation and neuroplasticity during periods of significant GI inflammation. A murine model of pediatric IBD and the mechanism(s) in which the microbiota‐gut‐brain axis is altered during this developmental time have yet to be identified. Aim Our goal was to develop a pediatric model of IBD and assess the effect on the microbiota‐gut‐brain axis at adulthood. Hypothesis We hypothesized that induction of ulcerative colitis by dextran sodium sulfate (DSS) at weanling mice (P21) would lead to lasting effects on the microbiota‐gut‐brain axis into adulthood, including behavioral deficits. Methods C57BL/6 mice (male and female) were weaned (P21) and treated with 2% DSS (or vehicle) for 5 days in the drinking water. In early adulthood (6–8 weeks of age), behavioral tests were performed (novel object recognition task [NOR], light/dark [L/D] box and open field test [OFT]) and tissue samples collected for PCR, immunofluorescence and microbiota analysis. Results DSS‐treated mice showed impaired object recognition and increased anxiety‐like behaviors compared to vehicle controls. Hippocampal gene expression showed increased expression of the pattern recognition receptors (Nod1 and Nod2), inflammatory cytokines (IL17ar, IL23 and IL22) along with a decreased expression of the neuronal activation markers (cFOS). Cell proliferation in the hippocampal dentate gyrus as quantified by doublecortin (DCX) staining showed significantly less DCX than vehicle controls. Finally, microbiota assessment identified persistent dysbiosis in DSS‐treated mice on alpha diversity, taxa abundance and phylum abundance compared to vehicle controls. Conclusions Taken together, these results indicate that acute DSS‐induced colitis in early adolescence can have long‐lasting effects on the microbiota‐gut‐brain axis in adulthood. Future studies will assess whether administration of probiotics can ameliorate these colitis‐induced microbiota‐gut‐brain axis deficits. Support or Funding Information Funding provided by Crohn’s & Colitis Foundation (CCFA)
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.